Risk & Weakness
Going Concern (Distress Proxy)
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 9 hits from US
Going concern refers to serious doubt about whether a company can continue to operate. This scanner takes the classic warning signs: Altman Z″ in the distress zone (<1.1), interest coverage <1 (earnings don't cover interest), and negative operating cash flow (burning cash). Note: this is a quantitative proxy, NOT the actual auditor's note from the annual report — we could add that via an EDGAR text search ('substantial doubt … going concern').
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Altman Z-Score
- A bankruptcy early-warning system developed by Edward Altman: several balance-sheet ratios are combined into one score. Values above 3 are considered a safe zone, values below about 1.1 a distress zone with elevated bankruptcy risk.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Going Concern
- The assumption in a company's annual report that it can continue operating. If auditors raise "substantial doubt" about this, it is one of the sharpest warnings there is - the company could run out of cash.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FIRY FIRY | 08/06 | — | — | Stage 2 | C -7 | 4 von 9 | 0.0 | Electronic Gaming & Multimedia | – | — | Communication Services | 8.00 $ | +111.6 % | — | — | — | — | 95 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -9.1 | 37.8 % | — | — | |
| RCUS Arcus Biosciences Inc | 08/05 | — | — | Stage 2 | D -33 | 0 von 9 | 3.8 | Biotechnology | – | — | Healthcare | 28.30 $ | +18.3 % | — | — | — | — | 93 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.0 | 72.4 % | — | — | |
| TSHA Taysha Gene Therapies Inc | 08/11 | — | — | Stage 2 | D -29 | 4 von 9 | 0.0 | Biotechnology | – | — | Healthcare | 5.70 $ | +24.7 % | — | — | — | — | 93 | 50 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.4 | 95.8 % | — | — | |
| FTRE Fortrea Holdings Inc. | 08/05 | — | — | Stage 2 | D -28 | 4 von 9 | 1.6 | Biotechnology | – | — | Healthcare | 18.00 $ | -4.6 % | — | — | — | — | 92 | 13 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.8 | 110.4 % | — | — | |
| REPL Replimune Group Inc | 07/02 | — | — | Stage 3 | D -35 | 1 von 9 | 0.9 | Biotechnology | – | — | Healthcare | 9.90 $ | +17.5 % | — | — | — | — | 92 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -8.4 | 96.9 % | — | — | |
| CYTK Cytokinetics Inc | 08/06 | — | — | Stage 2 | D -21 | 3 von 9 | 10.9 | Biotechnology | – | — | Healthcare | 81.90 $ | +25.9 % | — | — | — | — | 88 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -7.3 | 118.8 % | — | — | |
| HURA TuHURA Biosciences Inc | 08/13 | — | — | Stage 3 | E -61 | 3 von 9 | 0.2 | Biotechnology | – | — | Healthcare | 2.40 $ | +248.7 % | — | — | — | — | 86 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -16.0 | 15.0 % | — | — | |
| SPCE Virgin Galactic Holdings Inc | 08/05 | — | — | Stage 1 | D -21 | 3 von 9 | 0.3 | Aerospace & Defense | – | — | Industrials | 2.60 $ | -6.5 % | — | — | — | — | 43 | 42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -10.8 | 15.8 % | — | — | |
| SABR Sabre Corpo | 08/06 | — | — | Stage 3 | C -7 | 4 von 9 | 0.8 | Software - Infrastructure | – | — | Technology | 1.70 $ | +28.7 % | — | — | — | — | 36 | 6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 90.2 % | — | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Going concern refers to serious doubt about whether a company can continue to operate. This scanner takes the classic warning signs: Altman Z″ in the distress zone (<1.1), interest coverage <1 (earnings don't cover interest), and negative operating cash flow (burning cash).
All scanners are recalculated daily across the entire stock universe — most recently on 15. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 9 stocks pass this scanner's criteria (as of 15. July 2026).
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.